On the public citation graph
Integrated Analysis of VEGF and VEGFR Inhibitor-Induced Hypertension: Insights from Pharmacovigilance, Clinical Data, and Animal Models
0 signed · 51 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cncr.26491openalex-extracted
Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib
inferredcites →https://doi.org/10.1002/pds.1001openalex-extracted
The reporting odds ratio and its advantages over the proportional reporting ratio
inferredcites →https://doi.org/10.1002/pds.1742openalex-extracted
Quantitative signal detection using spontaneous ADR reporting
inferredcites →https://doi.org/10.1002/pds.3805openalex-extracted
Standardisation of the FAERS database: a systematic approach to manually recoding drug name variants
inferredcites →https://doi.org/10.1007/s00228-015-1935-7openalex-extracted
Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
inferredcites →https://doi.org/10.1007/s00432-023-05092-4openalex-extracted
Influence of background cardiovascular risk factors on VEGF inhibitor-related adverse vascular events in patients with non-small cell lung cancer: a retrospective study
inferredcites →https://doi.org/10.1007/s10456-017-9552-yopenalex-extracted
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
inferredcites →https://doi.org/10.1007/s11906-018-0871-1openalex-extracted
Management of VEGF-Targeted Therapy-Induced Hypertension
inferredcites →https://doi.org/10.1007/s11912-018-0708-8openalex-extracted
Tyrosine Kinase Inhibitor-Induced Hypertension
inferredcites →https://doi.org/10.1007/s11912-022-01224-0openalex-extracted
VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications
inferredcites →https://doi.org/10.1007/s12064-012-0162-3openalex-extracted
Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples
inferredcites →https://doi.org/10.1007/s40264-020-00911-wopenalex-extracted
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
inferredcites →https://doi.org/10.1016/j.ejca.2015.10.006openalex-extracted
Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?
inferredcites →https://doi.org/10.1016/j.jash.2018.03.008openalex-extracted
Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
inferredcites →https://doi.org/10.1016/j.ophtha.2020.07.062openalex-extracted
Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice
inferredcites →https://doi.org/10.1016/j.oraloncology.2022.106231openalex-extracted
The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A meta-analysis
inferredcites →https://doi.org/10.1016/j.redox.2015.09.036openalex-extracted
Treatment Of Sunitinib-Induced Hypertension In Solid Tumors By Nitric Oxid Donors
inferredcites →https://doi.org/10.1016/s0140-6736(05)67725-2openalex-extracted
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors
inferredcites →https://doi.org/10.1038/380439a0openalex-extracted
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
inferredcites →https://doi.org/10.1038/nrc909openalex-extracted
VEGF and the quest for tumour angiogenesis factors
inferredcites →https://doi.org/10.1038/sdata.2016.26openalex-extracted
A curated and standardized adverse drug event resource to accelerate drug safety research
inferredcites →https://doi.org/10.1038/sj.bjc.6604352openalex-extracted
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
inferredcites →https://doi.org/10.1046/j.1365-2796.1996.47870000.xopenalex-extracted
Impaired suppression of plasma free fatty acids and triglycerides by acute hyperglycaemia‐induced hyperinsulinaemia and alterations in high density lipoproteins in essential hypertension
inferredcites →https://doi.org/10.1073/pnas.0506580102openalex-extracted
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
inferredcites →https://doi.org/10.1074/jbc.m113.496802openalex-extracted
Inositol 1,4,5-Trisphosphate (IP3) Receptor Up-regulation in Hypertension Is Associated with Sensitization of Ca2+ Release and Vascular Smooth Muscle Contractility
inferredcites →https://doi.org/10.1080/14712598.2019.1594770openalex-extracted
Acute blood pressure elevation associated with biological therapies for cancer: a focus on VEGF signaling pathway inhibitors
inferredcites →https://doi.org/10.1093/annonc/mdm550openalex-extracted
Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation
inferredcites →https://doi.org/10.1093/jnci/djr128openalex-extracted
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
inferredcites →https://doi.org/10.1097/hjh.0000000000003480openalex-extracted
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
inferredcites →https://doi.org/10.1097/icu.0000000000000757openalex-extracted
Drug-related adverse effects of antivascular endothelial growth factor agents
inferredcites →https://doi.org/10.1111/ajco.12747openalex-extracted
Female sex, good performance status, and bevacizumab‐induced hypertension associated with survival benefit in Asian patients with recurrent glioblastoma treated with bevacizumab
inferredcites →https://doi.org/10.1161/circulationaha.120.049606openalex-extracted
Red Blood Cell and Endothelial eNOS Independently Regulate Circulating Nitric Oxide Metabolites and Blood Pressure
inferredcites →https://doi.org/10.1161/hypertensionaha.111.00841openalex-extracted
Role of Endogenous Vascular Endothelial Growth Factor in Endothelium-Dependent Vasodilation in Humans
inferredcites →https://doi.org/10.1161/hypertensionaha.117.08856openalex-extracted
Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition
inferredcites →https://doi.org/10.1161/hypertensionaha.117.10271openalex-extracted
Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular Disease
inferredcites →https://doi.org/10.1161/hypertensionaha.117.10490openalex-extracted
VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive Processes
inferredcites →https://doi.org/10.1186/1471-2105-14-7openalex-extracted
GSVA: gene set variation analysis for microarray and RNA-Seq data
inferredcites →https://doi.org/10.1186/1471-2288-12-81openalex-extracted
To test or not to test: Preliminary assessment of normality when comparing two independent samples
inferredcites →https://doi.org/10.1186/bcr2901openalex-extracted
Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study
inferredcites →https://doi.org/10.1186/s12910-020-00538-7openalex-extracted
Researchers’ views on, and experiences with, the requirement to obtain informed consent in research involving human participants: a qualitative study
inferredcites →https://doi.org/10.1200/jco.2005.02.7235openalex-extracted
Risk of Selected Subsequent Carcinomas in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
inferredcites →https://doi.org/10.1200/jco.2016.34.4_suppl.749openalex-extracted
Phase II study of irinotecan and bevacizumab plus alternate day S-1 as second-line treatment in patients with metastatic colorectal cancer.
inferredcites →https://doi.org/10.1248/bpb.b17-00605openalex-extracted
Hypertension and Proteinuria as Predictive Factors of Effects of Bevacizumab on Advanced Breast Cancer in Japan
inferredcites →https://doi.org/10.2165/11590180-000000000-00000openalex-extracted
Bevacizumab-Induced Hypertension
inferredcites →https://doi.org/10.2174/1389450115666141120120145openalex-extracted
Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer: A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.3121/cmr.4.3.218openalex-extracted
Gene Therapy for Cancer Treatment: Past, Present and Future
inferredcites →https://doi.org/10.3322/caac.21660openalex-extracted
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
inferredcites →https://doi.org/10.3322/canjclin.55.2.74openalex-extracted
Global Cancer Statistics, 2002
inferredcites →https://doi.org/10.3389/fphar.2023.1249845openalex-extracted
Epirubicin and gait apraxia: a real-world data analysis of the FDA Adverse Event Reporting System database
inferredcites →https://doi.org/10.3390/cancers15205012openalex-extracted
VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.